Home › Interstitial Lung Diseases › Illinois › Chicago
Pag-aaral pangklinika para sa Interstitial Lung Diseases sa Chicago, IL
Isang pag-aaral para sa Interstitial Lung Diseases ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Nagre-recruitObservasyonal na pag-aaral
- University of Chicago, Chicago
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Nagre-recruit
- Northwestern University, Chicago
- University of Illinois Health, Chicago
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Nagre-recruitPhase 2/3
- Northwestern Memorial Hospital, Chicago
- The University of Chicago Medical Center, Chicago
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
Nagre-recruitPhase 3
- Northwestern University, Chicago
Pulmonary Fibrosis Foundation Community Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Pulmonary Fibrosis Foundation, Chicago
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Nagre-recruitPhase 2/3
- GSK Investigational Site, Chicago
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Nagre-recruitPhase 2
- Clinical Research Site, Chicago
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Nagre-recruitObservasyonal na pag-aaral
- Northwestern University, Chicago
Platform Clinical Study for Conquering Scleroderma
Nagre-recruitPhase 2
- The University of Chicago Medical Center (UCMC), Chicago
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Nagre-recruitPhase 3
- Northwestern Memorial Hospital, Clinical Research Unit, Chicago
- Rush University Medical Center Outpatient Pulmonary Clinic, Chicago
- UI Health Hospital, Chicago
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- University of Chicago, Chicago
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Nagre-recruitPhase 2
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
- aTyr Investigative Site, Chicago
Pag-aaral para sa Interstitial Lung Diseases sa ibang lungsod
- New York City, NY17 pag-aaral
- Philadelphia, PA16 pag-aaral
- Los Angeles, CA14 pag-aaral
- Kansas City, KS13 pag-aaral
- Durham, NC13 pag-aaral
- Houston, TX12 pag-aaral
- Charleston, SC11 pag-aaral
- Ann Arbor, MI11 pag-aaral
- Aurora, CO10 pag-aaral
- Boston, MA9 pag-aaral
- Rochester, MN9 pag-aaral
- Salt Lake City, UT9 pag-aaral
Iba pang pag-aaral sa Chicago
- Kanser sa Suso59 pag-aaral
- Non-Small Cell Lung Cancer59 pag-aaral
- Kanser (lahat ng uri)51 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Kanser sa Baga43 pag-aaral
- Metastatic Cancer42 pag-aaral
- Obesity40 pag-aaral
- Kanser sa Ovary36 pag-aaral
- Colorectal Cancer32 pag-aaral
- Stroke31 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg29 pag-aaral
- Overweight29 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.